A Biotech Company Had $268 Million in Cash. After a Failed Drug Trial, It Announced a 46 Percent Workforce Cuttranslating…

The biotech company is downsizing to fund another trial after a drug showed no meaningful benefit. The move comes just a year after its IPO.

Factuality

74/100

Political Bias

Left

Ownership

Mansueto Ventures

Country

USA

Region

North America

Language

English

Keywords#Biotech#Drug#Trial#A Biotech#A Biotech Company